Current and Emerging Treatment Perspectives in Heart Failure

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: 30 October 2024 | Viewed by 452

Special Issue Editor


E-Mail Website
Guest Editor
Cardiology Division, Internal Medicine Department, Ivrea Hospital, 10015 Turin, Piedmont, Italy
Interests: heart failure; treatment perspectives; emerging therapies; cardiac imaging; diagnostics; risk stratification; prognosis; patient outcomes

Special Issue Information

Dear Colleagues,

This Special Issue titled “Current and Emerging Treatment Perspectives in Heart Failure” in clinical medicine covers the latest advancements and approaches in managing heart failure, a complex and potentially life-threatening condition. This Special Issue provides valuable insights into the diagnosis, treatment, and management strategies for heart failure patients.

One of the key areas discussed in this Special Issue is the use of novel diagnostic techniques to accurately assess heart function and identify the underlying causes of heart failure. Advanced imaging modalities, such as cardiac magnetic resonance imaging (MRI) and echocardiography, are highlighted for their ability to provide detailed information about cardiac structure and function.

In terms of treatment, this Special Issue emphasizes on the importance of a multidisciplinary approach involving cardiologists, cardiac surgeons, and other healthcare professionals. It explores various interventions, including pharmacological therapies, device interventions, surgical advancements, precision medicine, and regenerative medicine.

Overall, this Special Issue provides a comprehensive overview of the current and emerging treatment perspectives in heart failure. It serves as a valuable resource for healthcare professionals involved in the care and management of patients with this challenging condition.

Dr. Walter Grosso Marra
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart failure
  • treatment perspectives
  • emerging therapies
  • cardiac imaging
  • diagnostics
  • risk stratification
  • prognosis
  • patient outcomes

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 1665 KiB  
Review
Novel Techniques, Biomarkers and Molecular Targets to Address Cardiometabolic Diseases
by Valerio Di Fiore, Federica Cappelli, Lavinia Del Punta, Nicolò De Biase, Silvia Armenia, Davide Maremmani, Tommaso Lomonaco, Denise Biagini, Alessio Lenzi, Matteo Mazzola, Domenico Tricò, Stefano Masi, Alessandro Mengozzi and Nicola Riccardo Pugliese
J. Clin. Med. 2024, 13(10), 2883; https://doi.org/10.3390/jcm13102883 - 14 May 2024
Viewed by 375
Abstract
Cardiometabolic diseases (CMDs) are interrelated and multifactorial conditions, including arterial hypertension, type 2 diabetes, heart failure, coronary artery disease, and stroke. Due to the burden of cardiovascular morbidity and mortality associated with CMDs’ increasing prevalence, there is a critical need for novel diagnostic [...] Read more.
Cardiometabolic diseases (CMDs) are interrelated and multifactorial conditions, including arterial hypertension, type 2 diabetes, heart failure, coronary artery disease, and stroke. Due to the burden of cardiovascular morbidity and mortality associated with CMDs’ increasing prevalence, there is a critical need for novel diagnostic and therapeutic strategies in their management. In clinical practice, innovative methods such as epicardial adipose tissue evaluation, ventricular–arterial coupling, and exercise tolerance studies could help to elucidate the multifaceted mechanisms associated with CMDs. Similarly, epigenetic changes involving noncoding RNAs, chromatin modulation, and cellular senescence could represent both novel biomarkers and targets for CMDs. Despite the promising data available, significant challenges remain in translating basic research findings into clinical practice, highlighting the need for further investigation into the complex pathophysiology underlying CMDs. Full article
(This article belongs to the Special Issue Current and Emerging Treatment Perspectives in Heart Failure)
Show Figures

Figure 1

Back to TopTop